Abstract
Despite the fact that the drug-eluting stents (DES) have markedly reduced neointimal proliferation, restenosis is still an open subject. Although DES fracture is very rare, it has been considered as one of the reasons for DES restenosis, however, the mechanism and proper management are not clearly elucidated yet. We describe two cases of sirolimus-eluting stent fracture combined with significant restenosis and suggest the possible revascularization strategies for successful management.
Original language | English |
---|---|
Pages (from-to) | 417-419 |
Number of pages | 3 |
Journal | International Journal of Cardiology |
Volume | 120 |
Issue number | 3 |
DOIs | |
Publication status | Published - 2007 Sept 3 |
Keywords
- Drug-eluting stent
- Restenosis
- Revascularization
- Stent fracture
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine